ANI Pharmaceuticals director proposes $374K share sale

Accepted by SEC EDGAR 07/07/2026 - 04:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ANI Pharmaceuticals, Inc. director Patrick Walsh reported a proposed sale of 4,336 common shares for an aggregate market value of $373,719.84, with an approximate sale date of July 7, 2026. The shares were acquired from the issuer as restricted stock on May 22, 2026. ANI Pharmaceuticals listed 22,734,618 common shares outstanding.

Key Figures

Proposed sale: 4,336 shares Aggregate market value: $373,719.84 Common shares outstanding: 22,734,618 shares +4 more

7 metrics

Proposed sale 4,336 shares Common shares; approximate sale date July 7, 2026

Aggregate market value $373,719.84 Proposed sale

Common shares outstanding 22,734,618 shares Listed as outstanding

Prior sale 10,000 shares May 13, 2026

Gross proceeds $806,300 Sale on May 13, 2026

Prior sale 3,973 shares May 11, 2026

Gross proceeds $320,819.75 Sale on May 11, 2026

Key Terms

Restricted Stock, Aggregate Market Value, Gross Proceeds

3 terms

Restricted Stock financial

"Nature of Acquisition Transaction: Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Gross Proceeds financial

"Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ANIP shares does Patrick Walsh plan to sell?

Patrick Walsh, an ANI Pharmaceuticals, Inc. director, reported a proposed sale of 4,336 common shares with an aggregate market value of $373,719.84. The approximate sale date is July 7, 2026.

Which broker is listed for Patrick Walsh's ANIP share sale?

Morgan Stanley Smith Barney LLC is listed as the broker for the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001720568
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI Pharmaceuticals, Inc.
SEC File Number	001-31812
Address of Issuer	104 CARNEGIE CENTER DRIVE SUITE 300 PRINCETON NEW JERSEY 08540
Phone	(609) 759-1810
Name of Person for Whose Account the Securities are To Be Sold	PATRICK WALSH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4336	373719.84	22734618	07/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/22/2026	Restricted Stock	Issuer			4336	05/22/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PATRICK WALSH 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	05/13/2026	10000	806300.00
PATRICK WALSH 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	05/11/2026	3973	320819.75

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Patrick Dennis Walsh
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)